Brought to you by 
DePuy Mitek gets additional rights to Anika's Orthovisc
02 Oct 2008
Executive Summary
DePuy Mitek (a division of Johnson & Johnson) will exclusively market and distribute Anika Therapeutics' (developing treatments to protect, heal, and repair tissues) hyaluronic acid products Orthovisc and Orthovisc mini in Central, Latin, and South America, including the Caribbean and Mexico, over a five-year period.
Deal Industry
- Biotechnology
- Medical Devices
-
Medical Devices
- Biomaterials
Deal Status
- Final
Deal Type
-
Alliance
- Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
DePuy Mitek gets additional rights to Anika's Orthovisc
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice